NCT07304947 Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery
| NCT ID | NCT07304947 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Moyamoya Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 94 participants |
| Start Date | 2025-12-02 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 94 participants in total. It began in 2025-12-02 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease. Patients are randomized 1:1 to goal-directed fluid therapy based on baseline cardiac index versus standard arterial pressure-based management. The primary outcome is the incidence of transient ischemic episodes during hospitalization.
Eligibility Criteria
Inclusion Criteria: * Pediatric patients \<18 years undergoing EDAS for Moyamoya disease under general anesthesia Exclusion Criteria: * ASA physical status 4-5 * Emergency surgery * Known cardiovascular disease * Any condition judged inappropriate by investigators
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07304947 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 18 Years, studying Moyamoya Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07304947 currently recruiting?
Yes, NCT07304947 is actively recruiting participants. Contact the research team at jb4001@snu.ac.kr for enrollment information.
Where is the NCT07304947 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07304947 clinical trial?
NCT07304947 is sponsored by Seoul National University Hospital. The trial plans to enroll 94 participants.